Healthcare -
Biotechnology - NASDAQ - US
$ 1.185
-4.44 %
$ 52.8 M
Market Cap
-0.78
P/E
HOWL - COST OF REVENUE
Cost of Revenue HOWL - Werewolf Therapeutics, Inc.
38.9 M
LAST VALUE
627.55%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR